CRISPR Therapeutics Ltd header image

CRISPR Therapeutics Ltd

CRSP

Equity

ISIN CH0334081137 / Valor 33408113

NASDAQ (2026-03-27)

USD 45.75-3.79%

CRISPR Therapeutics Ltd
UMushroom community rating:

4.06 16 votes No rating yet

NegativeNeutralPositive

About company

CRISPR Therapeutics Ltd is a biotechnology company that focuses on developing gene-editing therapies. One of their key products is CASGEVY™, a CRISPR/Cas9 gene-edited therapy developed in collaboration with Vertex Pharmaceuticals Incorporated, which has received approval in some countries for treating patients with sickle cell disease or transfusion-dependent beta thalassemia. The company's innovative approach to gene editing has the potential to revolutionize the treatment of genetic diseases, offering hope to patients with previously untreatable conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

20.3%1Y

3.16%3Y

-58.9%5Y

Performance

61.6%1Y

58.1%3Y

60.1%5Y

Volatility

4391 M

Market cap (USD)

1,594,437

Daily traded volume (Shares)

39.67 / 38.21

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.06

16 votes

Performance:

3.88

Innovation:

4.81

Society:

4.19

Nature:

3.63

Shayaan Haider

United Kingdom, 08 Nov 2025

Great

Fabio Kull

Switzerland, 27 Oct 2025

The stock moves a lot with news on clinical trials — big potential, but also high risk.

Mark Hernandez

United Kingdom, 23 Oct 2025

Very good

EQUITIES OF THE SAME SECTOR

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc Valor: 30877188

Annual Return

-50%0%+50%

Risk level

110

-2.82%USD 72.15

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Valor: 23194616

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 131.87

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-7.98%USD 18.16

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 69.23

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 27.27

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

1.56%EUR 26.00

Guardant Health Inc

Guardant Health Inc Valor: 43633454

Annual Return

-50%0%+50%

Risk level

110

-3.96%USD 84.61

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.57%EUR 78.90

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.10%CHF 312.50

Align Technology Inc

Align Technology Inc Valor: 1159441

Annual Return

-50%0%+50%

Risk level

110

-6.17%USD 166.38

SIX

FactSet

Clearbit

Logos provided by Clearbit